Risk factors for opioid overdose and awareness of overdose risk among veterans prescribed chronic opioids for addiction or pain

Journal of Addictive Diseases

Volumn 35, Issue 1, 2016, Pages 42-51

  Wilder, Christine M ^a,b   Miller, Shannon C ^a,b   Tiffany, Elizabeth ^b   Winhusen, Theresa ^b   Winstanley, Erin L ^c   Stein, Michael D ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

chronic pain; medication assisted treatment; opioids; Overdose; risk assessment; veterans

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CARISOPRODOL; METHADONE; ZOLPIDEM; NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ADULT; ANALGESIA; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DRUG OVERDOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPIATE ADDICTION; PRESCRIPTION; QUESTIONNAIRE; RISK FACTOR; SLEEP DISORDERED BREATHING; VETERAN; VISUAL ANALOG SCALE; ADDICTION; ADVERSE EFFECTS; AGED; OPIOID-RELATED DISORDERS; UNITED STATES;

ADULT; AGED; ANALGESICS, OPIOID; BEHAVIOR, ADDICTIVE; BUPRENORPHINE; CHRONIC PAIN; DRUG OVERDOSE; FEMALE; HUMANS; MALE; METHADONE; MIDDLE AGED; MIDWESTERN UNITED STATES; OPIOID-RELATED DISORDERS; PAIN MANAGEMENT; PRESCRIPTION DRUGS; RISK FACTORS; VETERANS;

EID: 84955286901     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2016.1107264     Document Type: Article

References (45)

1. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers - United States, 1999-2008. Morbidity & Mortality Weekly Report 2011; 60:1487-92.
2. Centers for Disease Control and Prevention. Opioid overdoses in the United States. Journal of Pain & Palliative Care Pharmacotherapy 2012; 26:44-7.
3. Centers for Disease Control and Prevention. National Center for Injury Prevention and Control: data and statistics web-based injury statistics query and reporting system 2005. http://www.cdc.gov/injury/wisqars/LeadingCauses.html (accessed October 20, 2014).
4. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiology & Drug Safety 2006; 15:618-27.
5. Beauchamp G, Winstanley E, Ryan S, Lyons M. Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic. Am J Public Health 2014; 104:2023-9.
6. Shepperd JA, Klein WM, Waters EA, Weinstein ND. Taking stock of unrealistic optimism. Perspect Psychol Sci 2013; 8:395-411.
7. Weinstein ND. Unrealistic optimism about future life events. J Personal Soc Psychol 1980; 39:806-20.
8. Giangregorio L, Dolovich L, Cranney A, et al. Osteoporosis risk perceptions among patients who have sustained a fragility fracture. Patient Education & Counseling 2009; 74:213-20.
9. Brown EJ. College students' AIDS risk perception. J Psychosoc Nursing & Mental Health Serv 1998; 36:25-30.
10. Green J, Grant M, Hill KL, Brizzolara J, Belmont B. Heart disease risk perception in college men and women. J Am College Health 2003; 51:207-11.
11. Singer M, Dai H, Weeks MR, Malave D. AIDS risk perception among women drug users in Hartford, CT. Women & Health 1998; 27:67-85.
12. Crisp BR, Barber JG, Ross MW, Wodak A, Gold J, Miller ME. Injecting drug users and HIV/AIDS: risk behaviours and risk perception. Drug Alcohol Depend 1993; 33:73-80.
13. Johnston CL, Marshall BDL, Qi J, et al. HIV knowledge and perceptions of risk in a young, urban, drug-using population. Pub Health 2011; 125:791-4.
14. Frank D, Mateu-Gelabert P, Guarino H, et al. High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid users. Int J Drug Policy 2015; 26:84-91.
15. Coffin PO, Tracy M, Bucciarelli A, Ompad D, Vlahov D, Galea S. Identifying injection drug users at risk of nonfatal overdose. Acad Emer Med 2007; 14:616-23.
16. Stoove MA, Dietze PM, Jolley D. Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data. Drug Alcohol Rev 2009; 28:347-52.
17. Britton PC, Wines JD, Jr., Conner KR. Non-fatal overdose in the 12 months following treatment for substance use disorders. Drug Alcohol Depend 2010; 107:51-5.
18. Jenkins LM, Banta-Green CJ, Maynard C, et al. Risk factors for nonfatal overdose at Seattle-area syringe exchanges. J Urban Health 2011; 88:118-28.
19. Dietze P, Jolley D, Fry CL, Bammer G, Moore D. When is a little knowledge dangerous? Circumstances of recent heroin overdose and links to knowledge of overdose risk factors. Drug Alcohol Depend 2006; 84:223-30.
20. Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999. Am J Public Health 2001; 91:1842-6.
21. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008; 300:2613-20.
22. Brugal MT, Barrio G, De LFL, Regidor E, Royuela L, Suelves JM. Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. Addiction 2002; 97:319-27.
23. Dietze P, Jolley D, Fry C, Bammer G. Transient changes in behaviour lead to heroin overdose: results from a case-crossover study of non-fatal overdose. Addiction 2005; 100:636-42.
24. Binswanger IA, Stern MF, Deyo RA, et al. Release from prison - a high risk of death for former inmates. N Engl J Med 2007; 356:157-65.
25. Merrall ELC, Kariminia A, Binswanger IA, et al. Meta-analysis of drug-related deaths soon after release from prison. Addiction 2010; 105:1545-54.
26. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Annals of Internal Med 2010; 152:85-92.
27. Bohnert A, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011; 305:1315-21.
28. Centers for Disease Control and Prevention. Vital signs: risk for overdose from methadone used for pain relief - United States, 1999-2010. Morbidity & Mortality Weekly Report 2012; 61:493-7.
29. Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert A. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. British Med J 2015; 350:h2698.
30. Bohnert A, Ilgen MA, Trafton JA, et al. Trends and regional variation in opioid overdose mortality among Veterans Health Administration patients, fiscal year 2001 to 2009. Clin J Pain 2014; 30:605-12.
31. Bohnert A, Ilgen MA, Ignacio RV, McCarthy JF, Valenstein M, Blow FC. Risk of death from accidental overdose associated with psychiatric and substance use disorders. Am J Psych 2012; 169:64-70.
32. Bennett AS, Elliott L, Golub A. Veterans' health and opioid safety - contexts, risks, and outreach implications. Federal Practitioner 2015; 32:4-7.
33. Substance Abuse and Mental Health Services Administration. Federal guidelines for opioid treatment programs. Vol HHS Publication No. (SMA) PEP 15-FEDGUI-DEOTP. Rockville, MD, 2015.
34. Bush K, Kivlahan D, McDonell M, Fihn S, Bradley K. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med 1998; 158:1789-95.
35. Yudko E, Lozhkina O, Fouts A. A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. J Subst Abuse Treat 2007; 32:189-98.
36. Svendsen K, Borchgrevink P, Fredheim O, Hamunen K, Mellbye A, Dale O. Choosing the unit of measurement counts: the use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses. Palliative Med 2011; 25:725-32.
37. Williams A, Strang J, Marsden J. Development of Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales for take-home naloxone training evaluation. Drug Alcohol Depend 2013; 132:383-6.
38. Strang J, Manning V, Mayet S, et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction 2008; 103:1648-57.
39. Tobin KE, Sherman SG, Beilenson P, Welsh C, Latkin CA. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy 2009; 20:131-6.
40. Shepperd JA, Carroll P, Grace J, Terry M. Exploring the causes of comparative optimism. Psychol Belgica 2002; 42:65-98.
41. Berdine HJ, Nesbit SA. Equianalgesic dosing of opioids. J Pain Palliative Care Pharmacother 2006; 20:79-84.
42. Knotkova H, Fine PG, Portenoy RK. Opioid rotation: the science and the limitations of the equianalgesic dose table. J Pain Sympt Manag 2009; 38:426-39.
43. Shaheen PE, Walsh D, Lasheen W, Davis MP, Lagman RL. Opioid equianalgesic tables: are they all equally dangerous? J Pain Sympt Manage 2009; 38:409-17.
44. O'Bryant CL, Linnebur SA, Yamashita TE, Kutner JS. Inconsistencies in opioid equianalgesic ratios: clinical and research implications. J Pain Palliative Care Pharmacother 2008; 22:282-90.
45. Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E. Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing. J Pain Sympt Manage 2001; 22:672-87.